Search
Results (1429)
Chemistry in Question is a By-Product of Manufacturing Processes, Not Intentionally Added to Detergents, Cleaning Products
The Environmental Protection Agency (EPA) used “outdated, very limited data” to rapidly conclude that there are ‘unreasonable risks’ from 1,4-dioxane as a byproduct, according to comments submitted by the American Cleaning Institute (ACI).
1,4-Dioxane is a byproduct of manufacturing processes for some surfactants (the workhorse…
Features CDC Expert
Designed to Support Personnel in K-12 Schools and Early Care Education
Schools play a central role in slowing the spread of diseases in communities by providing healthy, safe, and supportive learning environments for students. To support these efforts, the American Cleaning Institute (ACI) is hosting a webinar covering best practices and key prevention strategies to keep students, staff, and school communities healthy.
The free webinar, “Clean Hands and…
Federal Level Focus Includes Supply Chain Issues, Support for EPA Funding
“State of the Association” Highlighted at ACI’s 2022 Mid-Year Meeting
The cleaning product supply chain will face increased state-level legislative and regulatory activities in the second half of 2022, potentially affecting chemical ingredient, packaging and cleaning product use and disposal issues, according to Melissa Hockstad, President and CEO of the American Cleaning…
Phosphate
SDA
1992
ACI Convention Set for Jan. 29-Feb. 2, Orlando, FL
Are you interested in innovations that will enhance the cleaning product supply chain? Join us during the Innovation Showcase at the 2024 American Cleaning Institute (ACI) Annual Meeting & Industry Convention.
The Showcase will take place January 31 during ACI’s Convention Week, January 29-February 2 at the Grande Lakes Orlando in Orlando, Florida.
The Innovation Showcase – now in its eighth year…
At Congressional Hearing, ACI Highlights Research Efforts to Meet FDA Requirements on Antibacterial Soap Safety EfficacyAlso Urges Agency to Improve Communications, Response Efforts with Manufacturers Providing Research UpdatesThe Food and Drug Administration (FDA) should consider options that would protect manufacturers who invest in research to help meet the agency’s data requests from ‘free-riders’ who benefit from the results of that work without paying a dime.That was the message delivered…
Volatile Organic Compounds
CHM2Hill
1994